AcyclovirAntiviral AgentsHerpes SimplexVirus ReplicationGanciclovirOrganophosphonatesFoscarnetHerpes ZosterSimplexvirusViral Plaque AssayProdrugsHerpes GenitalisHerpesvirus 2, HumanRimantadineValineNucleosidesDrug Resistance, ViralAmantadineGuanineHerpesvirus 1, HumanHerpes LabialisTrifluridineHerpesvirus 3, HumanInterferonsIdoxuridineOseltamivirVero CellsInfluenza, HumanArabinofuranosyluracilRibavirinCytosineCytomegalovirusCell Line2-AminopurineZanamivirThymidine KinaseCytomegalovirus InfectionsAdministration, OralAdministration, TopicalEncephalitis, Herpes SimplexHerpes Zoster OphthalmicusHepacivirusHIV-1Cercopithecus aethiopsOintmentsVidarabineOrganophosphorus CompoundsVirus DiseasesVirus ActivationVirusesStomatitis, HerpeticInterferon-alphaZidovudineRNA, ViralDrug Therapy, CombinationDNA, ViralKeratitis, DendriticAnti-HIV AgentsZalcitabineViral ProteinsRibonucleosidesHerpesviridae InfectionsAdenineInfluenza A Virus, H1N1 SubtypeInfluenza B virusInfluenza A virusPost-Exposure ProphylaxisOrthomyxoviridaeHepatitis B virusHerpesviridaeVirus SheddingLamivudineReverse Transcriptase InhibitorsChickenpoxPyransHIVInhibitory Concentration 50Drug Resistance, MicrobialHepatitis B, ChronicViral Nonstructural ProteinsHepatitis C, ChronicInterferon Type IMolecular Sequence DataDrug Evaluation, PreclinicalRecurrenceCells, CulturedBell PalsyViral LoadEncephalitis, Varicella ZosterTime FactorsDNA-Directed DNA PolymeraseSkin Diseases, ViralImmunocompromised HostArabinonucleotidesVidarabine PhosphatePhosphonoacetic AcidHIV InfectionsVirus InternalizationMicrobial Sensitivity TestsTreatment Outcome